This article is more than 5 years old. Information may no longer be current.
ASTRO appoints scientific affairs director
Click Here to Manage Email Alerts
The American Society for Radiation Oncology named Judy Keen, PhD, as its director of scientific affairs.
The society created the position to grow research participation and collaboration in the field of radiation oncology.
Keen will develop and implement initiatives that promote clinical, translational and basic radiation research. She will strive to grow research participation among radiation oncologists by managing the various funding mechanisms offered by ASTRO, such as its junior faculty awards and seed grants, as well as finding and promoting opportunities from external funding agencies. She also will lead efforts to develop broader collaborations in the cancer research community and serve as ASTRO’s primary scientific liaison to internal and external partners involved in biomedical research.
“Judy understands the fundamental role of research and science in helping radiation oncology teams provide the best possible care to their patients, which we can see from her extensive background both conducting research and promoting scientific activities,” Laura Thevenot, CEO of ASTRO, said in a press release. “I welcome her expertise and look forward to leveraging ASTRO’s position as the world’s premier radiation oncology society to further advance scientific knowledge within radiation biology and oncology.”
Keen previously served as director of research collaborations for the National Breast Cancer Coalition, as well as a health science analyst and program director at NCI. She also spent several years as assistant professor in the department of medicine at Robert Wood Johnson Medical School at University of Medicine and Dentistry of New Jersey, where she focused on ways to improve responses to chemotherapy in breast cancer.